Toronto, Ontario–(Newsfile Corp. – September 8, 2021) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce the Company, in collaboration with KGK, a licensed CRO in Canada, is commencing the next preclinical trial study on Amanita…


Previous articleNo, VR Will Not Give You A Psychedelic Trip
Next articleRed Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering with Leading Canadian Fresh and Dried Mushroom Producers on East Coast Facility